Application 020604
- Type
- BLA
- Sponsor
- EMD SERONO
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 020604 | Serostim | somatropin | 351(a) | Rx | 2026-06-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SEROSTIM | SOMATROPIN | INJECTABLE;INJECTION | 6MG/VIAL | No | No |
| 002 | SEROSTIM | SOMATROPIN | INJECTABLE;INJECTION | 5MG/VIAL | No | No |
| 003 | SEROSTIM | SOMATROPIN | INJECTABLE;INJECTION | 4MG/VIAL | No | No |
| 004 | SEROSTIM | SOMATROPIN | INJECTABLE;INJECTION | 8.8MG/VIAL | No | No |
| 005 | SEROSTIM LQ | SOMATROPIN | INJECTABLE;SUBCUTANEOUS | 6MG/0.5ML (6MG/0.5ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Serostim | SOMATROPIN | EMD Serono, Inc. | 62b01d29-90f0-45b2-a0c4-3a750ba36c8a | 2026-07-28 | Warnings, Adverse reactions | BLA020604 44087-0006 44087-0004 44087-0005 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 44087-0004 | Serostim | somatropin | EMD Serono, Inc. | NDA | Current |
| 44087-0004 | Serostim | somatropin | EMD Serono, Inc. | BLA | Current |
| 44087-0004 | Serostim | somatropin | EMD Serono, Inc. | NDA | Current |
| 44087-0004 | Serostim | somatropin | EMD Serono, Inc. | BLA | Current |
| 44087-0005 | Serostim | somatropin | EMD Serono, Inc. | NDA | Current |
| 44087-0005 | Serostim | somatropin | EMD Serono, Inc. | BLA | Current |
| 44087-0005 | Serostim | somatropin | EMD Serono, Inc. | NDA | Current |
| 44087-0005 | Serostim | somatropin | EMD Serono, Inc. | BLA | Current |
| 44087-0006 | Serostim | somatropin | EMD Serono, Inc. | NDA | Current |
| 44087-0006 | Serostim | somatropin | EMD Serono, Inc. | BLA | Current |
| 44087-0006 | Serostim | somatropin | EMD Serono, Inc. | NDA | Current |
| 44087-0006 | Serostim | somatropin | EMD Serono, Inc. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 66561 | SUPPL | 2021-03-05 |
| 48547 | SUPPL | 2020-03-23 |
| 48526 | SUPPL | 2020-03-23 |
| 48361 | SUPPL | 2020-03-23 |
| 48336 | SUPPL | 2020-03-23 |
| 46200 | SUPPL | 2020-03-23 |
| 46187 | SUPPL | 2020-03-23 |
| 46156 | SUPPL | 2020-03-23 |
| 46155 | SUPPL | 2020-03-23 |
| 41475 | SUPPL | 2020-03-23 |
| 41474 | SUPPL | 2020-03-23 |
| 41473 | SUPPL | 2020-03-23 |
| 34948 | SUPPL | 2020-03-23 |
| 34947 | SUPPL | 2020-03-23 |
| 34946 | SUPPL | 2020-03-23 |
| 34945 | SUPPL | 2020-03-23 |
| 34944 | SUPPL | 2020-03-23 |
| 34943 | SUPPL | 2020-03-23 |
| 25305 | SUPPL | 2020-03-23 |
| 25304 | SUPPL | 2020-03-23 |
| 25303 | SUPPL | 2020-03-23 |
| 25302 | SUPPL | 2020-03-23 |
| 25301 | SUPPL | 2020-03-23 |
| 25300 | SUPPL | 2020-03-23 |
| 20760 | SUPPL | 2020-03-23 |
| 12829 | SUPPL | 2020-03-23 |
| 12828 | SUPPL | 2020-03-23 |
| 12827 | SUPPL | 2020-03-23 |
| 12826 | SUPPL | 2020-03-23 |
| 12825 | SUPPL | 2020-03-23 |
| 12824 | SUPPL | 2020-03-23 |
| 2859 | SUPPL | 2020-03-23 |
| 2858 | SUPPL | 2020-03-23 |
| 2857 | SUPPL | 2020-03-23 |
| 2856 | SUPPL | 2020-03-23 |
| 2855 | SUPPL | 2020-03-23 |
| 2854 | SUPPL | 2020-03-23 |
| 2853 | SUPPL | 2020-03-23 |
| 66423 | APPL | 2020-03-22 |